Herocore, founded in 2021, headquartered in Shanghai, is a holding subsidiary of Ruiying Pharmaceutical Group, one of the top 100 pharmaceutical companies in China. Relying on Ruiying's professional customized research and development capabilities of the whole API industry chain and its four production bases, Herocore is mainly engaged in the production, import and export sales of pharmaceutical products and providing CDMO services for global pharmaceutical companies.
